A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
for Atrial Fibrillation
5 locations incl. Tupelo
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07217067·Phase 2·Recruiting